Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, April 16, 2024 | Back issues
Courthouse News Service Courthouse News Service

Lipitor Antitrust

TRENTON, N.J. - Pfizer, Warner-Lambert, and Ranbaxy conspired to delay introduction of generic Lipitor to reap hundreds of millions of dollars in extra profits, Walgreen and others claim in a federal antitrust complaint.

For more securities news, click here to check out Courthouse News' Securities Law Review.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...